ProKidney Reports Third Quarter Financial Results : vimarsan

WINSTON-SALEM, N.C., Nov. 14, 2023 (GLOBE NEWSWIRE) -- ProKidney Corp. (Nasdaq: PROK) (“ProKidney”), a leading late clinical-stage cellular therapeutics...

Related Keywords

Ukraine , Glenn Schulman , James Coulston , Exchange Of Class , Nasdaq , Exchange Commission , Capital Suvretta Holdings Corp , Company Class , Lifesci Advisors , Prokidney Corp , Chief Financial Officer , Loss Before Noncontrolling Interest , Renal Autologous Cell Therapy , Regenerative Medicine Advanced Therapy , Private Securities Litigation Reform Act , Annual Report , Quarterly Reports , Sci Advisors , Months Ended September , Social Capital Suvretta Holdings , Business Combination , Nasdaq Prok , Prokidney ,